MULTIPLE SCLEROSIS JOURNAL, cilt.24, sa.9, ss.1205-1211, 2018 (SCI-Expanded)
Background: Women with multiple sclerosis (MS) experience an increased risk of relapse in the postpartum period. High-dose methylprednisolone is the first-line treatment for acute relapses.